# Sophia Genetics (SOPH) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/SOPH
## Company Profile
- Ticker: SOPH
- Exchange: NASDAQ
- Sector: Biopharma
- Location: Switzerland
## Stock Data
- Close: 8.3 USD
- Market cap: 354644408.04 USD
- Last updated: 2026-09-03
## Business Overview
Sophia Genetics is a healthcare technology company focused on data-driven diagnostics and clinical decision support. Its business is centered on applying software to genomic and pathology workflows.
## Why The Stock Is Moving

As of Sep 3, 2026, SOPH was little changed and closed at $8.30. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in Switzerland and listed on NASDAQ as an ADR, Sophia Genetics sits in healthcare data and diagnostics.

## Business Model

The company depends on software adoption, diagnostics workflows, and the value of its data platform across hospitals and labs.

## Landscape Position

Sophia Genetics is outside biotech proper and belongs to the diagnostics software layer.

## Future Catalysts

- SOPHiA Genetics’s catalysts are DDM platform adoption, companion-diagnostic partnerships, and recurring software revenue. The business improves when the analytics workflow becomes more embedded in clinical and biopharma use cases.

## Recent News
- 2024-06-24 13:47 EST — [SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting](https://biopharmsignal.com/news/SOPH/sophia-genetics-publishes-results-of-2024-annual-general-meeting-cd3af75f) — Source: Sophia Genetics
- 2024-05-07 10:45 EST — [SOPHiA GENETICS Reports First Quarter 2024 Results](https://biopharmsignal.com/news/SOPH/sophia-genetics-reports-first-quarter-2024-results-e1a64b37) — Source: Sophia Genetics
- 2024-04-30 11:05 EST — [SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference](https://biopharmsignal.com/news/SOPH/sophia-genetics-to-present-at-the-2024-rbc-capital-markets-global-healthcare-con-9aa966bb) — Source: Sophia Genetics
- 2024-04-23 14:29 EST — [SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024](https://biopharmsignal.com/news/SOPH/sophia-genetics-to-announce-financial-results-for-first-quarter-2024-on-may-7-20-f68ce487) — Source: Sophia Genetics
- 2024-03-07 17:07 EST — [SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference](https://biopharmsignal.com/news/SOPH/sophia-genetics-to-present-at-the-barclays-26th-annual-global-healthcare-confere-76cb280c) — Source: Sophia Genetics